Induction of cytotoxic T-lymphocyte responses

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4242041, 4242081, 4242771, 4242751, 4242831, 424400, A61K 39000, A61K 39008, A61K 3912, A61K 39390

Patent

active

057098603

ABSTRACT:
Methods and compositions useful for inducing a cytotoxic T lymphocyte response (CTL) in a human or domesticated or agriculturally important animal. The method includes the steps of providing the antigen to which the CTL response is desired and providing an antigen formulation which comprises, consists, or consists essentially of two or more of a stabilizing detergent, a micelle-forming agent, and an oil. This antigen formulation is preferably lacking in an immunostimulating peptide component, or has sufficiently low levels of such a component that the desired CTL response is not diminished. This formulation is provided as a stable oil-in-water emulsion.

REFERENCES:
patent: 4053585 (1977-10-01), Allison et al.
patent: 4117113 (1978-09-01), Allison et al.
patent: 4770874 (1988-09-01), Allison et al.
patent: 4772466 (1988-09-01), Allison et al.
patent: 4778784 (1988-10-01), Dreesman et al.
patent: 4963354 (1990-10-01), Shepard et al.
Staerz et al., Nature, 239:449, 1987.
Murphey-Corb et al., Science 246:1293, 1989.
Asherson et al., Immunology 22:465, 1972.
Berman et al., int. J. Cancer 2:539-543, 1967.
Letvin et al., Vaccines 87, Cold Spring Harbor Laboratory (1987).
Allison et al., Vaccines 87, Cold Spring Harbor Laboratory (1987).
Allison et al., Immunopharmacology of Infectious Diseases: Vaccine Adjuvants and Modulators of Non-Specific Resistance, pp. 191-201, 1987.
Allison, Immunopotentiation, Elsevier, Excerpta Medica, North Holland, pp. 73-99, 1973.
Morgan et al., J. Medical Virology, 29:74-78, 1989.
Kenney et al., J. Immunological Methods 121:157-166, 1989.
Allison et al., J. Immunological Methods 95:157-168, 1986.
Byars et al., 8 Vaccine 49, 1990.
Allison et al., Molecular Immunology 28(3):279-284, 1991.
Allison et al., Technological Advances in Vaccine Development, pp. 401-409, 1988.
Byars et al., 5 Vaccine 223, 1987.
Allison, "Non-Specific" Factors Influencing Host Resistance, pp. 247-258 (Karger, Basel 1973).
Mitchell et al., Journal of Clinical Oncology 8(5):856-869, 1990.
Allison et al., Immunology Today, vol. 11, No. 12, 1990.
Takahashi et al., Proc. Natl. Acad. Sci. USA 85:3105-3109, 1988.
Hunter et al., J. Immunology 133(6):3167, 1984.
Hunter et al., J. Immunology 127:1244, 1981.
Rickman et al., The Lancet 337:998, 1991.
Sanchez-Prescador et al., J. Immunology 141(5):1720-1727, 1988.
Morein et al., Immunological Adjuvants and Vaccines, Plenum Press, Published in cooperation with NATO Science Affairs Division, pp. 153-161 1990.
Takahashi et al., Nature, 344:873, 1990.
Allison et al., J. Immunological Methods 95:157-168, 1986.
Eppstein et al., Advanced Drug Delivery Reviews, 4:233-253, 1990.
Pluronic Surfactants brochure 1990.
Whittaker Bioproducts, Inc. brochure, 1989.
Khusmith et al., Science 252:715, 1991.
Shen et al., Science 252:440, 1991.
Rosenthal, New York Times 1991.
Kolata, New York Times, Apr. 19, 1991.
Rennie, Scientific American, Jul. 1991, p. 24.
Campbell et al., J. Immunology 139:2825, 1987.
Campbell et al., J. Immunology 145:1029, 1990.
Kwak et al., Blood 76(11):2411, 1990.
Wraith et al., J. gen. Virol 66:1327, 1985.
Goldstein et al., Chapter 4, mAbd To Human Lymphocyte Surface Antigens, p. 71.
C.K. Stover et al., Nature, 351:456-460, 1991.
L.W. Kwak et al., Idiotype Networks in Biology and Medicine, Elsevier Science Publishers, p. 163, 1990.
Allison, A.C. et al., 95 J. Imm. Methods 157-168 (1986.
Byars, N.E. et al., Vaccine 223-228 (1987).
Allison, A.C. et al., 11/12 Immunology Today 427-428 (1990).
Allison, A.C. et al., 28/3 Molecular Immunology 279-284 (1991).
Nicholas et al, 1991 Virology 182 pp. 664-672.
Kahn et al. 1991 J. Immunol H6(9)3235-41.
Sandra et al, 1995 JNCI 87(4)280-5.
Acres et al. 1993 J. Immunother. 14:136-43.
Alwan et al. 1992 Clin Exp. Immunol 88(3)527-536.
Peace et al, 1993 J. Immunother 14. 110-14.
Mackewicz et al, 1991 J Clin Invest 87 pp. 1462-1466.
Yen et al. Leukemia 7 Suppl 2527-30.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Induction of cytotoxic T-lymphocyte responses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Induction of cytotoxic T-lymphocyte responses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Induction of cytotoxic T-lymphocyte responses will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-723388

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.